BNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma (NHL)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN71826974

Enrollment

1000

Registered

2002-08-19

Start date

1997-04-30

Completion date

Unknown

Last updated

2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma (non-Hodgkin's) Cancer Lymphoma (non-Hodgkin's)

Interventions

Standard radiotherapy versus low dose radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Any patient receiving local radiotherapy (RT) where the aim of the treatment is local control of that lymphoma, whether as radical treatment of Stage I disease, consolidation therapy after chemotherapy or palliation 2. Histological diagnosis of NHL 3. Aged 18 years or over 4. Able to give informed consent

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026